Welcome to our dedicated page for Ainos news (Ticker: AIMD), a resource for investors and traders seeking the latest updates and insights on Ainos stock.
Ainos, Inc. (NASDAQ: AIMD) is a dual-platform AI and biotech company whose news flow is centered on its AI Nose SmellTech platform and related AI infrastructure, alongside development of its low-dose oral interferon candidate, VELDONA. Company updates frequently highlight progress in digitizing scent into Smell ID, expanding industrial deployments, and advancing its Smell Language Model (SLM) through its subsidiary ScentAI Inc.
On this page, readers can follow AIMD news related to industrial partnerships, commercialization milestones, and strategic agreements. Recent announcements have covered distribution and deployment partnerships in semiconductor front-end manufacturing, collaborations with industrial computing and edge AI providers, and expansion of AI Nose pilots across smart factories, robotics, and healthcare environments. Ainos also issues press releases on its GICS reclassification into the technology sector, intellectual property additions, and SmellTech-as-a-Service contracts.
Investors and observers can expect news items on topics such as multi-year SmellTech-as-a-Service agreements, pilot deployments in senior care and robotics, new patents for AI Nose and digital olfaction, and updates on the company’s platform strategy to separate sensing hardware (Ainos) from AI intelligence (ScentAI). Financial result releases and associated commentary provide additional context on research and development priorities and commercialization roadmaps.
By monitoring this news feed, users gain a consolidated view of how Ainos is building its SmellTech ecosystem across semiconductors, industrial automation, robotics, and healthcare, while continuing to develop its VELDONA oral interferon program. Bookmark this page for ongoing coverage of AIMD press releases, partnership announcements, and regulatory communications.
Ainos (NASDAQ:AIMD) is advancing its AI Nose SmellTech platform, positioning scent as a native AI data layer through standardized Smell IDs and a proprietary Smell Language Model. The company reported multi-year semiconductor back-end orders of approximately $2.1M for ~1,400 AI Nose units and highlighted robotics partnerships to scale continuous scent data generation in 2026.
The firm's dual-engine architecture separates physical sensing from intelligence-as-a-service (via subsidiary ScentAI) to pursue recurring subscription economics, broader industrial deployments across front-end and back-end semiconductor operations, and accelerated data flywheel growth via robotics partnerships.
Ainos (NASDAQ:AIMD) announced a technology partnership with Mirle Automation on February 2, 2026, to integrate Ainos' AI Nose scent‑digitizing platform into mobile and quadruped robotic platforms.
The collaboration targets inspection, monitoring, and autonomous tasks — detecting VOCs, gas leaks, and chemical anomalies — to boost robotic situational awareness and safety across fabs, manufacturing, healthcare, outdoor inspection, and security applications.
Ainos (NASDAQ:AIMD / AIMDW) will participate in a fireside chat with Water Tower Research on Monday, January 26, 2026 at 11:00 a.m. ET.
The company will discuss its dual-engine SmellTech platform, partnership with Trusval Technology, progress scaling AI Nose technology toward commercial deployment, and strategic priorities for 2026. The event is listen-only and a replay will be posted under "Events" on Ainos' investor relations site.
Ainos (NASDAQ:AIMD) is advancing AI Nose from R&D toward scaled commercial deployment in 2026, supported by a dual-engine architecture separating hardware sensing and a software ScentAI layer. A three-year distribution and deployment agreement with Trusval Technology includes an initial minimum commitment of 600 AI Nose units, targeting front-end semiconductor wafer fabrication and broader manufacturing use cases. The structure aims to enable recurring, SaaS-style revenue through APIs, licensing, and subscriptions while expanded deployments feed a growing Smell ID library and machine-learning performance. Ainos relocated its U.S. headquarters to Houston, Texas in early 2026 to align with industrial and semiconductor ecosystems.
Ainos (NASDAQ:AIMD) announced a distribution and deployment agreement with Taiwan-based Trusval Technology on January 7, 2026 to expand AI Nose into semiconductor front-end manufacturing.
Under the contract, Trusval will be Ainos' authorized sales agent and deployment partner for front-end wafer fab applications, with an initial minimum purchase commitment of 600 AI Nose units to support real-world deployments and scent data accumulation in high-precision manufacturing environments.
The deal extends Ainos' SmellTech footprint upstream from back-end processes and aligns with the company's 2026 execution focus on disciplined, contract‑driven platform expansion.
Ainos (NASDAQ:AIMD) outlined a long-term platform strategy to digitize smell as a native AI data language and described a dual-engine SmellTech architecture split between hardware sensing and AI intelligence.
Ainos will own design, manufacturing, deployment, and data generation for its AI Nose sensors while wholly owned ScentAI will develop the Smell Language Model (SLM) to classify, contextualize, and scale scent data via APIs, SaaS, and model licensing. 2026 priorities target scaled deployments in advanced semiconductor manufacturing and robotics to accelerate data accumulation and SLM training.
Ainos (NASDAQ:AIMD / AIMDW) will relocate its U.S. headquarters to Houston, Texas in early 2026 and has formed a wholly owned software subsidiary, ScentAI Inc.
ScentAI will develop a smell language model (SLM) that converts scent signals into Smell ID tokens and will be co-located with Ainos' HQ to integrate AI Nose hardware data with model development. Management described the move as improving operating efficiency and enabling U.S. commercialization after recent deployments in Asia.
Ainos (NASDAQ:AIMD) reported third-quarter 2025 developments as it accelerates commercial scale-up of its AI Nose scent‑digitization platform ahead of 2026. Key operational moves include expanding industrial partnerships to six, a distribution agreement with Topco across the U.S., Taiwan, Japan and Southeast Asia, a strategic partnership with NEXCOM (Oct 14, 2025), and reclassification under GICS to Technology Hardware, Storage & Peripherals effective Oct 1, 2025. The company launched its first commercial portable AI Nose (Aug 14, 2025) and added seven patents on Sep 30, 2025, bringing the total to 123 active patents. Management cited cost discipline with S,G&A down 22% YoY and total operating expenses down 8%.
Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM to integrate its AI Nose scent‑based edge AI solution into NEXCOM's industrial edge computing and automation platforms. The collaboration is Ainos' sixth industrial partnership in 2025 and aims to enable real‑time environmental sensing, predictive maintenance, and improved sustainability by processing olfactory data at the edge instead of the cloud. The deal leverages NEXCOM's network of 117 partners across 50 countries and aligns with an edge AI market projected at $57–$66 billion by 2030. Ainos targets a commercial launch in 2026 for AI Nose and cites enhanced industrial channels via NEXCOM's global footprint.
Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM on October 14, 2025 to integrate Ainos' AI Nose hardware, SmellTech, and Smell Language Model into NEXCOM's industrial edge AI and automation platforms.
The collaboration targets real-time environmental sensing for manufacturing and industrial applications, enabling intelligent monitoring, predictive maintenance, and sustainable operations while leveraging NEXCOM's global edge computing footprint and channels.